Articles
6 November 2020
16
0
5
0
Smart Citations
16
0
5
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

An emerging potential therapeutic target for osteoporosis: LncRNA H19/miR-29a-3p axis

Authors

Osteoporosis (OP) is a complex systemic disease characterized by a loss of bone density, leading to bone fragility and an increase risk of fractures of the hip, spine and wrist. The clinical therapeutic effect is still far from satisfactory. Thus, further studies are urgently needed to explore the pathogenesis of OP. In this study, our aim is to explore the underlying molecular mechanism of lncRNA H19/miR-29a-3p axis for regulating of inflammation, proliferation and apoptosis in OP. The expression of lncRNA H19 was significantly upregulated in OP samples compared with the health control. Subsequently, we found that miR-29a-3p is the target of lncRNA H19 in OP. Furthermore, the knockdown of lncRNA H19 was validated to promote the expression of pro-inflammatory mediators, repress cell proliferation and inhibit cell apoptosis in vitro. Moreover, the modulating effects of lncRNA-H19 on the expressions of pro-inflammatory mediators, cell proliferation and apoptosis in vitro were diminished after co-transfecting with miR-29a-3p inhibitor and siRNA-H19. Thus, we concluded that lncRNA H19/miR-29a-3p axis was involved in the development of OP. This study might provide a better understanding of OP development and a potential therapeutic target for OP intervention.

Altmetrics

Downloads

Citations

Crossref
14
Scopus
0
Crossref Logo
Kai Xia, Li-Yuan Yu, Xin-Qi Huang, Zhi-He Zhao, Jun Liu (2022)
Epigenetic regulation by long noncoding RNAs in osteo-/adipogenic differentiation of mesenchymal stromal cells and degenerative bone diseases. World Journal of Stem Cells, 14(1), 92.
Crossref Logo
Liang Wang, Lei Qi (2021)
The role and mechanism of long non-coding RNA H19 in stem cell osteogenic differentiation. Molecular Medicine, 27(1).
Crossref Logo
Wei Xiong, Dan Liu, Xi Chen, Leiting Liu, Weihong Xiao (2022)
lncRNA JPX modulates malignant progress of osteosarcoma through targeting miR-33a-5p and PNMA1 regulatory loop. Translational Oncology, 25, 101504.
Crossref Logo
Jiying Chen, Zhiying Zhu, Shi Xu, Jing Li, Lilan Huang, Wenqing Tan, Yonggang Zhang, Yanli Zhao (2023)
HDAC1 participates in polycystic ovary syndrome through histone modification by regulating H19/miR-29a-3p/NLRP3-mediated granulosa cell pyroptosis. Molecular and Cellular Endocrinology, 573, 111950.
Crossref Logo
Jianglin Hou, Da Liu, Jihui Zhao, Sen Qin, Senxiang Chen, Zimo Zhou (2023)
Long non-coding RNAs in osteoporosis: from mechanisms of action to therapeutic potential. Human Cell, 36(3), 950.
Crossref Logo
Małgorzata Rolla, Aleksandra Jawiarczyk-Przybyłowska, Katarzyna Kolačkov, Agnieszka Zembska, Marek Bolanowski (2023)
Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study. Biomedicines, 11(4), 1211.
Crossref Logo
Weifei Zhang, Yuheng Liu, Yuanrui Luo, Xiang Shu, Congmin Pu, Bin Zhang, Pin Feng, Ao Xiong, Qingquan Kong (2023)
New insights into the role of long non-coding RNAs in osteoporosis. European Journal of Pharmacology, 950, 175753.
Crossref Logo
Zhi Zeng, Liangyu Fei, Juntao Yang, Jun Zuo, Zelin Huang, Hao Li (2022)
MiR-27a-3p Targets GLP1R to Regulate Differentiation, Autophagy, and Release of Inflammatory Factors in Pre-Osteoblasts via the AMPK Signaling Pathway. Frontiers in Genetics, 12.
Crossref Logo
Pakkath Narayanan Arya, Iyyappan Saranya, Nagarajan Selvamurugan (2024)
RUNX2 regulation in osteoblast differentiation: A possible therapeutic function of the lncRNA and miRNA-mediated network. Differentiation, 140, 100803.
Crossref Logo
Yuanfeng Li, Shiqi Ye, Zhen Han, Chengjian Wei, Yingxuan Huang (2025)
LncRNA CRNDE ameliorates bone fracture by regulating cell viability and apoptosis of osteoblasts. Journal of Orthopaedic Surgery and Research, 20(1).
Crossref Logo
Claudio Casali, Stella Siciliani, Lorena Zannino, Marco Biggiogera (2022)
Histochemistry for nucleic acid research: 60 years in the European Journal of Histochemistry. European Journal of Histochemistry, 66(2).
Crossref Logo
Martina Faraldi, Paola Maroni, Marta Gomarasca, Veronica Sansoni, Giuseppe Banfi, Giovanni Lombardi (2024)
. Advances in Clinical Chemistry, 122, 141.
Crossref Logo
Xing Liu, LiJun Tian, ZhiGang Deng, YuSong Guo, SanBing Zhang (2024)
Zoledronic Acid Accelerates Bone Healing in Carpal Navicular Fracture via Silencing Long Non-coding RNA Growth Arrest Specificity 5 to Modulate MicroRNA-29a-3p Expression. Molecular Biotechnology, 66(11), 3238.
Crossref Logo
Ching-Tse Ting, Bor-Sen Chen (2022)
Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. International Journal of Molecular Sciences, 23(7), 3649.

Ethics Approval

Ethical approval was obtained for all experimental procedures by the Ethics Committee of the Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China

How to Cite



An emerging potential therapeutic target for osteoporosis: LncRNA H19/miR-29a-3p axis. (2020). European Journal of Histochemistry, 64(4). https://doi.org/10.4081/ejh.2020.3155